ARWR - CIK 0000879407
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,347 documents with the SEC between 1998 and 2026. The most frequent type is insider trade (434 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| 144/A | - | 2026-05-19 | - |
| 144/A | - | 2026-05-19 | - |
| 144/A | - | 2026-05-19 | - |
| Insider trade | 4 | 2026-05-14 | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-12 | - |
| Employee stock plan | S-8 | 2026-05-07 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| SCHEDULE 13G | - | 2026-05-06 | - |
| SCHEDULE 13G | - | 2026-04-29 | - |
| SCHEDULE 13G | - | 2026-04-28 | - |
| SCHEDULE 13G/A | - | 2026-04-24 | - |
| Insider trade | 4 | 2026-04-24 | 2026-04-23 |
| Insider trade | 4 | 2026-04-24 | 2026-04-22 |
| Insider sale notice | 144 | 2026-04-23 | - |
| Insider sale notice | 144 | 2026-04-22 | - |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Major company event | 8-K | 2026-03-20 | 2026-03-19 |
| Insider trade | 4 | 2026-03-09 | 2026-03-05 |
| Insider sale notice | 144 | 2026-03-05 | - |
| Quarterly report | 10-Q | 2026-02-05 | 2025-12-31 |
| Major company event | 8-K | 2026-02-05 | 2026-02-05 |
| Annual report to shareholders | ARS | 2026-01-27 | 2026-01-26 |
| Proxy materials | DEFA14A | 2026-01-27 | - |
| Proxy statement | DEF 14A | 2026-01-27 | 2026-01-26 |
| SCHEDULE 13G/A | - | 2026-01-21 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Major company event | 8-K | 2026-01-09 | 2026-01-07 |
| Prospectus supplement | 424B5 | 2026-01-09 | - |
| Prospectus supplement | 424B5 | 2026-01-09 | - |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| 305B2 | - | 2026-01-08 | - |
| Free writing prospectus | FWP | 2026-01-08 | - |
| Free writing prospectus | FWP | 2026-01-08 | - |
| Prospectus supplement | 424B5 | 2026-01-07 | - |
| Prospectus supplement | 424B5 | 2026-01-07 | - |
| Major company event | 8-K | 2026-01-06 | 2026-01-06 |
| Insider trade | 4 | 2026-01-05 | 2026-01-05 |
| 144/A | - | 2026-01-05 | - |
| Insider sale notice | 144 | 2026-01-05 | - |
| Insider sale notice | 144 | 2026-01-05 | - |
| Insider trade | 4 | 2026-01-05 | 2025-12-31 |
| Insider trade | 4 | 2026-01-05 | 2026-01-02 |
| Insider sale notice | 144 | 2026-01-02 | - |
| Insider trade | 4 | 2025-12-30 | 2025-12-26 |
| Insider trade | 4 | 2025-12-30 | 2025-12-29 |
| Insider sale notice | 144 | 2025-12-29 | - |
| Insider sale notice | 144 | 2025-12-29 | - |